Drug intelligence / Profile preview

Tiaoshen Jiangu Granules

Development stage: Preclinical
Lead developer: Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Tiaoshen Jiangu Granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Shanghai University of Traditional Chinese Medicine for the treatment of depression-type osteoporosis. This specific indication refers to the co-occurrence of osteoporosis and depressive symptoms, a clinical phenotype often addressed in TCM through the regulation of the liver and kidney systems to balance bone metabolism and emotional health. The drug is formulated as oral granules and is currently in the preclinical stage of development. The project is part of the Shanghai TCM Science and Technology Innovation Project and is being developed in collaboration with Chengji (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd.

Other names: 调神健骨颗粒Tiaoshen Jiangu Keli

Beyond the preview

Go deeper on Tiaoshen Jiangu Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiaoshen Jiangu Granules.

Explore the full profile